Advertisement

Jansen Jab Gets The EMA’s Go Ahead

The benefits of the Johnson & Johnson Covid-19 vaccine outweigh the risks - that’s what the...

Share this article

09.41 21 Apr 2021


Jansen Jab Gets The EMA’s Go Ahead


Listen to this episode


Share this article

09.41 21 Apr 2021


The benefits of the Johnson & Johnson Covid-19 vaccine outweigh the risks - that’s what the European Medicines Agency concluded yesterday. Concerns about the Jansen jab’s safety had been raised following reports of a small number of blood clots in US recipients. Professor of Experimental Immunology at Trinity College Dublin, Kingston Mills joined us this morning.

Listen and subscribe to Newstalk Breakfast on Apple Podcasts or Spotify.

   

Download, listen and subscribe on the Newstalk App.

  

You can also listen to Newstalk live on newstalk.com or on Alexa, by adding the Newstalk skill and asking: 'Alexa, play Newstalk'.


Read more about

Breakfast Covid Vaccine Jansen Vaccine Johnson And Johnson Newstalk Newstalk Breakfast Vaccine

Related Episodes

The Bookshelf with Pat Kenny

00:08:01

The Bookshelf with Pat Kenny

The Hard Shoulder Highlights

00:08:01


Dealing with turbulence when i...

00:04:32

Dealing with turbulence when it happens

The Hard Shoulder Highlights

00:04:32


New Housing Commission Report...

00:12:45

New Housing Commission Report with Darragh O’Brien

The Hard Shoulder Highlights

00:12:45


The practicalities and politic...

00:35:00

The practicalities and politics of Manchester City's 115 charges | Matt Slate on the Football Show

OTB Football

00:35:00